Table 4.

Lumican (LUM) expression correlated with clinicopathological parameters.

Clinicopathological parameters	Total (N)	Odds ratio in LUM expression	p-value
Age
<65 vs. ≥65	371	0.848 (0.561–1.282)	0.435
Gender
Male vs. female	371	0.992 (0.650–1.514)	0.969
Tumor differentiation
Poor vs. well or •moderate	366	1.543 (1.015–2.356)	0.043
Pathological stage
StageII vs. stageI	164	3.149 (1.591–6.452)	0.001
StageIII vs. stageI	203	2.505 (1.303–4.992)	0.007
StageIV vs. stageI	91	2.081 (0.880–5.008)	0.097
T classification
T2 vs. T1	99	13.304 (2.551–245.163)	0.014
T3 vs. T1	187	18.434 (3.677–335.410)	0.005
T4 vs. T1	119	30.649 (5.953–562.687)	0.001
Lymph node metastasis
Positive vs. negative	357	0.870 (0.555–1.363)	0.544
Distant metastasis
Yes vs. no	355	0.923 (0.404–2.094)	0.847

Bold values indicate P < 0.05.